Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Archives of Physical Medicine and Rehabilitation

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.APMR.2004.03.034PMID 15759224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gait in Children With Cerebral Palsy: Observer Reliability of Physician Rating Scale and Edinburgh Visual Gait Analysis Interval Testing Scale

  2005cited by this paper
• Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years.

  2001cited by this paper
• The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial

  2001cited by this paper
• Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome

  1999cited by this paper
• The Hip in Children With Cerebral Palsy: Predicting the Outcome of Soft Tissue Surgery

  1997cited by this paper
• AGE AND MIGRATION PERCENTAGE AS RISK FACTORS TOR PROGRESSION IN SPASTIC HIP DISEASE

  1995cited by this paper
• BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY

  1994cited by this paper
• EXTENSIBILITY OF HIP ADDUCTORS IN CHILDREN WITH CEREBRAL PALSY

  1994cited by this paper
• Long‐Term Follow‐up of Hip Subluxation in Cerebral Palsy Patients

  1993cited by this paper
• Dislocation of the hip in cerebral palsy: P.H. Cooke, W.G. Cole, and R.P.L., Coley. J Bone Joint Surg (Br) 71:441–446, (May), 1989

  1990cited by this paper
• NATURAL HISTORY AND PREDICTABILITY

  1989cited by this paper
• Dislocation of the hip in cerebral palsy. Natural history and predictability.

  1989cited by this paper
• Combined Adductor Transfer, Iliopsoas Release, and Proximal Hamstring Release in Cerebral Palsy

  1989cited by this paper
• Management of the hip in cerebral palsy.

  1986cited by this paper
• PREVENTION OF SPASTIC PARALYTIC DISLOCATION OF THE HIP

  1985cited by this paper
• The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy.

  1980cited by this paper
• Acetabular development in congenital dislocation of the hip. With special reference to the indications for acetabuloplasty and pelvic or femoral realignment osteotomy.

  1975cited by this paper

• Botulinum toxin injections for the treatment of hip instability in the pediatric population with cerebral palsy: a systematic review

  2025influential citation
• A pediatric physiatrist’s approach to neuromuscular hip dysplasia in cerebral palsy

  2022cites this paper
• Effect of Botulinum Toxin Injection on the Progression of Hip Dislocation in Patients with Spastic Cerebral Palsy: A Pilot Study

  2021cites this paper
• Orthopedic treatment of the lower limbs in spastic paralysis

  2020cites this paper
• Prophylactic Treatment of Hip Subluxation in Children with Cerebral Palsy

  2020cites this paper
• Migration percentage and odds of recurrence/subsequent surgery after treatment for hip subluxation in pediatric cerebral palsy: a meta-analysis and systematic review

  2019cites this paper
• Fate of stable hips after prophylactic femoral varization osteotomy in patients with cerebral palsy

  2018cites this paper
• Use of iliac crest allograft for Dega pelvic osteotomy in patients with cerebral palsy

  2018cites this paper
• Use of Botulinum Toxin A in Cerebral Palsy Use of Botulinum Toxin A in Cerebral Palsy

  2018cites this paper
• AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study

  2018cites this paper
• Prevention of hip displacement in children with cerebral palsy: a systematic review

  2017influential citation
• Early Botulinum Toxin Injections in Infants With Musculoskeletal Disorders: A Systematic Review of Safety and Effectiveness.

  2017cites this paper
• Progression of Hip Displacement during Radiographic Surveillance in Patients with Cerebral Palsy

  2016cites this paper
• Osteopenic features of the hip joint in patients with cerebral palsy: a hospital‐based study

  2016cites this paper
• Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy

  2016cites this paper
• Can we prevent hip dislocation in children with cerebral palsy? Effects of postural management.

  2016cites this paper
• Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy

  2015cites this paper
• Pain and disabilities related to hip disorders in adults with severe cerebral palsy

  2014cites this paper
• Recurrence of hip instability after reconstructive surgery in patients with cerebral palsy.

  2014cites this paper
• Hip Lateralisation in Children with Bilateral Spastic Cerebral Palsy Treated with Botulinum Toxin Type A: A 2-Year Follow-Up

  2011cites this paper
• The spastic foot: The perspective of the orthopedic surgeon

  2011cites this paper
• Impact of cognitive and functional sequellae on recurrence of excised HO in patients with traumatic brain injury: A case control study

  2011cites this paper
• Papel de la toxina botulínica tipo A en la prevención de la luxación de cadera en niños con parálisis cerebral

  2011cites this paper
• Efficacy of botulinum toxin type A treatment of functional impairment of degenerative hip joint: Preliminary results.

  2010cites this paper
• Transcutaneous electrical nerve stimulation of hip adductors improves gait parameters of children with spastic diplegic cerebral palsy.

  2010cites this paper
• Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy

  2010cites this paper
• [Botulinum toxin A in children with infantile cerebral palsy: indications and treatment concepts].

  2010cites this paper
• Clinical Relevance of Valgus Deformity of Proximal Femur in Cerebral Palsy

  2010cites this paper
• Botulinumtoxin A bei Kindern mit infantiler Zerebralparese

  2009cites this paper
• Botulinum toxin A for the prevention of hip dislocation in cerebral palsy

  2009cites this paper
• Disorders of the Brain

  2009cites this paper
• Safety of botulinum toxin type A in children younger than 2 years.

  2009cites this paper
• Comparison of botulinum toxin type A injection and soft-tissue surgery to treat hip subluxation in children with cerebral palsy.

  2008cites this paper
• Musculoskeletal complications of neuromuscular disease in children.

  2008cites this paper
• [Prophylaxis and therapy for hip dislocations in patients with infantile cerebral palsy (ICP): motor functional, radiological and clinical results after subcutaneous adductor tenotomy].

  2007cites this paper
• Safety and efficacy of botox injection in alleviating post-operative pain and improving quality of life in lower extremity limb lengthening and deformity correction

  2007cites this paper
• [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].

  2007cites this paper
• ' s response to reviews Title : Safety and Efficacy of Botox Injection in Alleviating Post-Operative Pain and Improving Quality of Life in Lower Extremity Limb Lengthening and Deformity Correction

  2007cites this paper
• Beidseitige Hüftgelenksluxation bei infantiler Zerebralparese: konservative Therapie der weniger betroffenen Seite bei gegenseitiger Adduktorentenotomie

  2007cites this paper
• [Bilateral hip dislocation in cerebral palsy children: conservative therapy of the less affected hip and adductor tenotomy of the opposite hip].

  2007cites this paper
• Prophylaxe und Therapie der Hüftgelenksluxation bei infantiler Zerebralparese (ICP): statomotorische, radiologische und klinische Ergebnisse nach subkutaner Adduktorentenotomie

  2007cites this paper
• The child with cerebral palsy: diagnosis and beyond.

  2006cites this paper
• Evaluation and treatment of hip dysplasia in cerebral palsy.

  2006cites this paper
• Does botulinum toxin A reduce adductor muscle spasticity in children with cerebral palsy?

  2006cites this paper
• Botulinum toxin and its orthopaedic applications.

  2006cites this paper
• Hip dislocation in cerebral palsy

  2005cites this paper